Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Essential role of CD56dimNKG2C+ NK cells trained by SARS-CoV-2 vaccines in protecting against COVID-19. | Mol Ther | 2025 | 40450518 | PubTator, text mining | PubMed |
| Adaptive NKG2C+ NK cells in cytomegalovirus seropositive individuals predominantly lack NKR-P1A receptor expression. | Eur J Immunol | 2025 | 40426298 | PubTator, text mining | PubMed |
| COVID-19 Induces Prolonged Immunological Exhaustion Leading to Relapse of Hematological Malignancies Except in Hematopoietic Cell Transplant Recipients. | Mediterr J Hematol Infect Dis | 2025 | 40375919 | PubTator, text mining | PubMed |
| The Influence of the COVID-19 Pandemic in NK Cell Subpopulations from CML Patients Enrolled in the Argentina Stop Trial. | Cells | 2025 | 40358152 | PubTator, text mining | PubMed |
| Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation. | Am J Transplant | 2025 | 40340029 | PubTator, text mining | PubMed |
| Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian Cancer. | Cancer Immunol Res | 2025 | 40293356 | PubTator, text mining | PubMed |
| Epigenetics of maternal-fetal interface immune microenvironment and placental related pregnancy complications. | Front Immunol | 2025 | 40248704 | PubTator, text mining | PubMed |
| Prognostic value of natural killer T cell related genes in acute myeloid leukemia. | Cancer Cell Int | 2025 | 40223063 | PubTator, text mining | PubMed |
| CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors. | Front Immunol | 2025 | 39958331 | PubTator, text mining | PubMed |
| Construction of the Single-Cell Landscape of Hashimoto's Thyroiditis Tissue and Peripheral Blood by Single-Cell RNA Sequencing. | Immun Inflamm Dis | 2025 | 39931830 | PubTator, text mining | PubMed |
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways. | Ann Rheum Dis | 2025 | 39919899 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis. | J Neuroinflammation | 2025 | 39849490 | PubTator, text mining | PubMed |
| The Association of HLA-E Ligand and NKG2 Receptor Variation With Relapse and Mortality After Haploidentical Related Donor Transplantation. | Transplant Cell Ther | 2025 | 39798802 | PubTator, text mining | PubMed |
| Polycytotoxic T cells mediate antimicrobial activity against intracellular Mycobacterium tuberculosis. | Infect Immun | 2025 | 39660897 | PubTator, text mining | PubMed |
| Scalable nonparametric clustering with unified marker gene selection for single-cell RNA-seq data. | bioRxiv | 2025 | 38405697 | PubTator, text mining | PubMed |
| Natural killer cell engagers for cancer immunotherapy. | Front Oncol | 2024 | 39911822 | PubTator, text mining | PubMed |
| Immune Cell Distributions in the Blood of Healthy Individuals at High Genetic Risk of Parkinson's Disease. | Int J Mol Sci | 2024 | 39769417 | PubTator, text mining | PubMed |
| Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study. | Med Microbiol Immunol | 2024 | 39724280 | PubTator, text mining | PubMed |
| Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer. | Breast Cancer Res | 2024 | 39643914 | PubTator, text mining | PubMed |
| Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma. | Anticancer Res | 2024 | 39626933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=6